DIFFUSE LARGE B-CELL LYMPHOMA STAGE II

This adverse event was reported 64 times

DIFFUSE LARGE B-CELL LYMPHOMA STAGE II is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NITROFURANTOIN (MACROCRYSTALS) 1 0.0016
1 TERCONAZOLE 1 0.0012
2 AMISULPRIDE 5 0.0008
3 VINBLASTINE SULFATE 1 0.0005
4 CALCIPOTRIENE 1 0.0003
5 SALINE NASAL SPRAY 1 0.0002
6 POLATUZUMAB VEDOTIN 2 0.0002
7 FLUOXETINE HCL 1 0.0002
8 IFOSFAMIDE FOR INJECTION 3 0.0001
9 VINCRISTINE SULFATE 4 0.0001
See all drugs enriched for association with DIFFUSE LARGE B-CELL LYMPHOMA STAGE II